Why is Tatva Chintan falling/rising?

As of 01-September, Tatva Chintan Pharma Chem Ltd's stock price is currently at 1,041.00, reflecting an increase of 1.65 (0.16%). Despite this slight uptick today, the stock has underperformed its sector by 0.64%. It opened with a gain of 2.8% and reached an intraday high of Rs 1068.45. However, the stock has shown a decline of 6.65% over the past month and a significant drop of 57.79% over the last three years. The company maintains a low Debt to Equity ratio of 0.07, which is a positive factor, and has managed to generate an 8.32% return over the past year, contrasting with the negative performance of the broader market.
In the broader market context, the stock's recent performance has been relatively strong compared to the benchmark, as it has outperformed the BSE500 index, which has seen a decline of 4.75% over the last year. However, the stock's short-term performance is concerning, given the 3.31% drop over the past week while the Sensex fell only 1.56%. Additionally, there has been a notable decrease in investor participation, with delivery volume falling by 51.42% against the 5-day average, indicating reduced interest in trading the stock. This combination of factors suggests that while the stock has some positive attributes, its recent performance and declining investor engagement may be contributing to a cautious outlook.